Evidence map›Paper›PMID 19289843›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Molecular recognition and self-assembly special feature: Supramolecular polymer formed by reversible self-assembly of tetrakisporphyrin.

Takeharu Haino, Takashi Fujii, Akihide Watanabe, Urara Takayanagi

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Chiral Induction of a Tetrakis(porphyrin) in Various Chiral Solvents.Chemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Chemoresponsive alternating supramolecular copolymers created from heterocomplementary calix[4]pyrroles.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takeharu HainoDepartment of Chemistry, Graduate School of Science, Hiroshima University, Higashi-Hiroshima, Hiroshima, Japan. haino@sci.hiroshima-u.ac.jp
Takashi Fujii
Akihide Watanabe
Urara Takayanagi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

S-shaped tetrakisporphyrin 2 forms supramolecular polymeric assemblies via a complementary affinity of its bisporphyrin units in solution. The self-association constant determined by applying the isodesmic model is >10(6) L mol(-1), which suggests that a sizable polymer forms at millimolar concentrations at room temperature. The electron deficient aromatic guest (TNF) binds within the molecular clefts provided by the bisporphyrin units via a charge-transfer interaction. This guest complexation completely disrupts supramolecular polymeric assembly. The long, fibrous fragments of the polymeric assemblies were characterized by atomic-force microscopy imaging of a film cast on a mica surface. The polymeric assemblies have lengths of >1mum and show a coiled structure with a higher level of organization. The approach discussed in this report concerning the quick preparation of supramolecular polymeric assemblies driven by noncovalent forces sets the stage for the preparation of a previously undescribed class of macromolecular porphyrin architectures.

Indexed as

DimerizationFluorenesKineticsMagnetic Resonance SpectroscopyMicroscopy, Atomic ForceModels, ChemicalModels, MolecularMolecular StructurePolymersPorphyrins2,4,7-trinitrofluorenone5,10,15,20-tetrakis(3,5-dihydroxyphenyl)porphyrinFluorenesPolymersPorphyrins

Identifiers

PMID19289843
PMCPMC2705564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.